• Clinically Proven. US FDA Cleared.

    Award Winning Innovation.

  • How iBreastExam Works

    ACOG TV Award & Thought Leader Recognition

     

     

  •  

    1

    Breast Lumps

    Breast lumps (lesions) are stiffer than healthy breast tissue. Difference in their tissue elasticity is measurable

    2

    Tactile Imaging

    Dynamic Co-Planar Capacitive Sensors in iBreastExam measure these changes in real-time, digitally and non-invasively

    3

    Detection

    iBreastExam standardizes lump detection with minimal training and without requiring user interpretation

    4

    Documentation

    Quick & painless documentation of routine breast exams inform and empower care providers and women alike

  • Independent Global Validations

    With over 25,000 Women Enrolled

     

  • Powerful Posters

    Presented at Leading Conferences & Events

    Diagnostic accuracy of a novel palpation device to improve early detection of breast cancer in low-resource settings
    Study of accuracy of iBreastExam as a screening modality to detect breast lump - Experience of a tertiary care center in
    Clinical efficacy evaluation of a novel palpation imaging device for early detection of breast cancer in the developing

  • Science behind iBreastExam

    Invented at Drexel University, Philadelphia

     

    iBreastExam's Dynamic Co-Planar Capacitive Sensors accurately assess & identify tissue elasticity differences between hard & stiff breast tumors versus normal breast tissue in real-time. The patented tactile sensor technology is a novel, quantitative and low-cost elastic modulus sensor that can measure tissue compression and stiffness by top down touching of the skin surface. iBreastExam’s ability to apply a gentle force and measure the subtle displacements electrically, all within the sensor, makes for an ideal ‘electronic palpation’ sensor for in-vivo breast examination.

    broken image

  • Get to know our advisors and hear from global thought leaders.

  • We are Supported

    The translational research and commercialization of iBreastExam is supported by:

    broken image

    Coulter Program

     

    broken image

    QED & DHA Programs

     

    broken image

    CURE Grant Award

     

    broken image

    Global Health

    Innovation Grant

     

    broken image

    Grants4Impact 

    Award

     

    broken image

    Oncology

    Innovation Award​

     

  • Ongoing Large Scale Implementations

    Large-scale implementations in collaboration with public health agencies

    broken image

    India (Medical Colleges)

    broken image

    Mexico

     

    broken image

    Malaysia

     

  • Ask a Question. Request a Demo.

    Get in touch with us to learn more about iBreastExam

    USA - Philadelphia
    India - Mumbai, Bangalore, Delhi
    Malaysia - Kuala Lumpur
    +1.267.225.0453 (USA) +91.22.2610.2610 (India) +60.3.62063079 (Malaysia)
    +1.267.225.0453 (USA) +91.22.2610.2610 (India) +60.3.62063079 (Malaysia)
    info@UELifeSciences.com
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More